Letters
Breast cancer screening review
The proposed review will not be independent without NICE
BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d7533 (Published 22 November 2011) Cite this as: BMJ 2011;343:d7533
- Karsten Juhl Jørgensen, researcher1,
- Peter C Gøtzsche, professor1
- 1Nordic Cochrane Centre, Rigshospitalet, Blegdamsvej 9, DK-2100 Copenhagen, Denmark
- kj{at}cochrane.dk
Mike Richards and Harpal Kumar, chief executive at Cancer Research UK, were put in charge of the review but neither is independent.
For Richards, this is reflected in the references he chose for his letter.1 The first is used to support his claim of a 35% effect of breast screening in attenders, although they are healthier than non-attenders. The estimate is therefore misleading.
The second …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £164 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.